A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. (Q50561584)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 1998

Language	Label	Description	Also known as
English	A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.	scientific article published in February 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

adaptive radiation therapy

0 references

0 references

0 references

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J Overgaard

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H S Hansen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Overgaard

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Berthelsen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Lindeløv

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Jørgensen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Radiotherapy and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

135-146

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Accelerated fractionation: what is the price for speeding?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoxia-Specific Cytotoxins in Cancer Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

ARCON—Current Status: Summary of a Workshop on Preclinical and Clinical Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

How to read a paper: Statistics for the non-statistician. II: "Significant" relations and their pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitization of hypoxic tumour cells--clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the pharmacokinetic properties of nimorazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of tumors by the induction of anemia and irradiation in hyperbaric oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I clinical study of Nimorazole as a hypoxic radiosensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900220-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0167-8140(97)00220-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9510041%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50561584&oldid=1587475388"